World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
82
Citations
29671
World Ranking
928
National Ranking
68

Gordon Peters publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Gordon Peters sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 164 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Gordon Peters D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Gordon Peters sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 82 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Gordon Peters was affiliated with the Cancer Research UK London Research Institute in the United Kingdom. Their research contributions were situated primarily within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work also intersected with multiple specialized subfields, including Pulmonary and Respiratory Medicine, Molecular Biology, Genetics, Physiology, and Immunology.

The main topics covered in Peters' research encompassed Prostate Cancer Treatment and Research, Cancer-related Gene Regulation, Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities, Telomeres, Telomerase, and Senescence, Immunotherapy and Immune Responses, as well as Xenotransplantation and Immune Response.

The scientist published in several noted venues, with known publications in:

  • Oncogene
  • Cancer Research

Among their recent papers were:

  • Retraction Note: CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus (2022, Oncogene)
  • Editor's Note: Immortalization of Primary Human Prostate Epithelial Cells by c-Myc (2022, Cancer Research)

Peters collaborated frequently with several researchers, including:

  • David Bernard
  • Amancio Carnero
  • David Beach
  • Jesús Gil
  • Juan Fernando Martínez-Leal

The body of work by Gordon Peters touched on key aspects of cancer biology and gene regulation related to prostate cancer, incorporating genetic and immune response components. Their contributions spanned molecular mechanisms with implications for therapeutic interventions.

Best Publications

  • The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2

    Francesca J. Stott;Stewart Bates;Marion C. James;Beth B. McConnell

  • p14ARF links the tumour suppressors RB and p53.

    Stewart Bates;Andrew C. Phillips;Paula A. Clark;Francesca Stott

  • The p16INK4a/CDKN2A tumor suppressor and its relatives

    Margarida Ruas;Gordon Peters

  • Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

    Jiri Lukas;David Parry;Louise Aagaard;David J. Mann

  • Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer.

    Marcia Hall;Gordon Peters

  • Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence.

    E Hara;R Smith;D Parry;H Tahara

  • Regulation of the INK4b-ARF-INK4a tumour suppressor locus : all for one or one for all

    Jesús Gil;Gordon Peters

  • Amplification and Overexpression of Cyclin D1 in Breast Cancer Detected by Immunohistochemical Staining

    Cheryl Gillett;Vera Fantl;Rosalind Smith;Charlotte Fisher

  • Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence.

    Naoko Ohtani;Zoe Zebedee;Thomas J. G. Huot;Julie A. Stinson

  • Glycolytic Enzymes Can Modulate Cellular Life Span

    Hiroshi Kondoh;Matilde E. Lleonart;Matilde E. Lleonart;Jesus Gil;Jesus Gil;Jing Wang

  • D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.

    Lammie Ga;Fantl;Smith R;Schuuring E

  • Expression of the FGF-related proto-oncogene int-2 during gastrulation and neurulation in the mouse.

    D G Wilkinson;G Peters;C Dickson;A P McMahon

  • Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product

    D Parry;S Bates;D J Mann;G Peters

  • Tumorigenesis by mouse mammary tumor virus: Proviral activation of a cellular gene in the common integration region int-2

    C. Dickson;R. Smith;S. Brookes;G. Peters

  • Potential oncogene product related to growth factors.

    Clive Dickson;Gordon Peters

  • Tumorigenesis by mouse mammary tumor virus: Evidence for a common region for provirus integration in mammary tumors

    Gordon Peters;Sharon Brookes;Rosalind Smith;Clive Dickson

  • Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts

    Beth B. McConnell;Maria Starborg;Sharon Brookes;Gordon Peters

  • Subcellular Fate of the int-2 Oncoprotein Is Determined by Choice of Initiation Codon

    Piers Acland;Mark Dixon;Gordon Peters;Clive Dickson

  • CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.

    Bates S;Bonetta L;MacAllan D;Parry D

  • Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS

    Marta Barradas;Emma Anderton;Juan Carlos Acosta;Si De Li

Frequent Co-Authors

Clive Dickson
Clive Dickson Cancer Research UK London Research Institute
Jesús Gil
Jesús Gil Imperial College London
Eiji Hara
Eiji Hara Osaka University
David A.D. Parry
David A.D. Parry Massey University
Karen H. Vousden
Karen H. Vousden The Francis Crick Institute
David Beach
David Beach Cold Spring Harbor Laboratory
Nelleke A. Gruis
Nelleke A. Gruis Leiden University Medical Center
Amancio Carnero
Amancio Carnero Spanish National Research Council
Robert J. Moore
Robert J. Moore RMIT University
Brigitte Bressac-de Paillerets
Brigitte Bressac-de Paillerets Institut Gustave Roussy

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology opens doors to a wide range of online degrees and career pathways, especially in healthcare and research fields. For those interested in advancing quickly, direct entry msn online programs offer fast tracks for non-nurses to secure advanced roles in nursing and clinical research.

Already a registered nurse? Deciding between top online bridge programs can be challenging. If you're weighing your options, compare capella vs wgu rn to bsn to ensure you choose the program that aligns best with your career goals, flexibility needs, and budget.

Many aspiring professionals also seek affordable advancement opportunities. Exploring online bsn to msn programs can help you move into leadership or specialized roles without breaking the bank.

When pursuing any degree online, make accreditation and reputation your priorities. Choosing non profit colleges can ensure a high-quality education with better student outcomes and support as you step into your chosen career.

Best Scientists Citing Gordon Peters

Recently Published Articles